British Columbia Investment Management Corp Regeneron Pharmaceuticals, Inc. Transaction History
British Columbia Investment Management Corp
- $15.9 Billion
- Q4 2024
A detailed history of British Columbia Investment Management Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 20,761 shares of REGN stock, worth $14.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
20,761
Previous 18,083
14.81%
Holding current value
$14.3 Million
Previous $19 Million
22.21%
% of portfolio
0.09%
Previous 0.12%
Shares
30 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.38 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.85 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.32 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.25 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...